Washington Trust Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.43K | Sell |
117
-135
| -54% | -$7.42K | ﹤0.01% | 541 |
|
|
2025
Q1 | $17.8K | Hold |
252
| – | – | ﹤0.01% | 406 |
|
|
2024
Q4 | $16.6K | Buy |
252
+65
| +35% | +$4.27K | ﹤0.01% | 423 |
|
|
2024
Q3 | $13.1K | Buy |
187
+28
| +18% | +$1.97K | ﹤0.01% | 447 |
|
|
2024
Q2 | $13.1K | Hold |
159
| – | – | ﹤0.01% | 435 |
|
|
2024
Q1 | $13.9K | Hold |
159
| – | – | ﹤0.01% | 435 |
|
|
2023
Q4 | $15.3K | Buy |
159
+41
| +35% | +$3.95K | ﹤0.01% | 425 |
|
|
2023
Q3 | $10.4K | Buy |
118
+21
| +22% | +$1.86K | ﹤0.01% | 456 |
|
|
2023
Q2 | $8.41K | Hold |
97
| – | – | ﹤0.01% | 483 |
|
|
2023
Q1 | $9.43K | Sell |
97
-53
| -35% | -$5.15K | ﹤0.01% | 508 |
|
|
2022
Q4 | $15.5K | Sell |
150
-301
| -67% | -$31.2K | ﹤0.01% | 450 |
|
|
2022
Q3 | $38K | Hold |
451
| – | – | ﹤0.01% | 421 |
|
|
2022
Q2 | $37K | Buy |
451
+82
| +22% | +$6.73K | ﹤0.01% | 443 |
|
|
2022
Q1 | $29K | Sell |
369
-265
| -42% | -$20.8K | ﹤0.01% | 530 |
|
|
2021
Q4 | $56K | Buy |
+634
| New | +$56K | ﹤0.01% | 451 |
|